The CF-CIRC Study: Assessing Cystic Fibrosis Diagnosis in Newborns
Author Information
Author(s): Sermet-Gaudelus Isabelle, Roussel Delphine, Bui Stéphanie, Deneuville Eric, Huet Frédéric, Reix Philippe, Bellon Gabriel, Lenoir Gérard, Edelman Aleksander
Primary Institution: Service de Pédiatrie Générale and CRCM, Hôpital Necker-Enfants Malades, Paris, France
Hypothesis
Can nasal potential difference (NPD) measurements serve as a reliable diagnostic tool for cystic fibrosis in infants with borderline neonatal screening results?
Conclusion
The study aims to validate NPD testing as a diagnostic tool for children with inconclusive neonatal screening results for cystic fibrosis.
Supporting Evidence
- Newborn screening programs for cystic fibrosis can prevent malnutrition and minimize lung damage.
- Measurements of nasal potential differences have been validated in adults and provide a quick diagnostic tool.
- The study includes a modified protocol for measuring NPD in infants, which has shown to be well tolerated.
- Previous studies indicate that early diagnosis of cystic fibrosis is crucial for effective treatment.
Takeaway
This study is trying to find a better way to diagnose cystic fibrosis in babies who might not show clear signs of the disease.
Methodology
The study involves measuring nasal potential differences in 20 children with cystic fibrosis and 20 healthy controls using a specially designed catheter and modified protocol.
Potential Biases
Potential bias in recruiting healthy controls from siblings of CF patients.
Limitations
The study may not account for variations in nasal epithelium maturation in infants compared to older children.
Participant Demographics
Children aged 3 months to 3 years, including 20 with cystic fibrosis and 20 healthy controls.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website